
Genfoquest Analytica
Innovative solutions for data-driven life sciences
We Simplify Bioinformatics for You
Who we are
Genfoquest Analytica (GQA) is a big data analytics company with a specific focus on bioinformatics. Founded in 2022 at Ege Teknopark, Izmir, Türkiye, we are dedicated to democratizing multi-omics insights through fast, scalable bioinformatics solutions.
Our core expertise lies in AI-powered software for transcriptomics, single-cell analysis, and drug discovery. We process large-scale omics data, enabling biomarker discovery via cell atlas generation.

Unlocking genomic insights
From individual sequences to population-level haplotypes, our bioinformatics pipelines extract meaningful patterns from complex genomic data.

What we provide
End-to-end workflow engineering for specialized molecular data structures
Data Curation & Quality Control
Standard data quality control procedures and curation for downstream analysis.
Data Analytics & Interpretation
Standard or customized analysis pipelines for your research needs.
Machine Learning & AI
Advanced predictive models and pattern recognition for genomic insights.
Consulting & Experience Exchange
We are always with you on your project, providing expert guidance.
Our software solutions
Purpose-built software architecture for precision task management
Smart Bioinformatics Interface (SBI)
Enterprise-grade bioinformatics solution used by leading pharmaceutical companies including Boehringer Ingelheim.
Processed over 2TB of data for 1M+ cell RNA-seq atlas
Single Cell Quest (SCQ)
Your personalized bioinformatics space for single-cell analysis. Submit analysis tasks, monitor progress, and collaborate with colleagues.
Available at scq.genfoquest.com
Visit platformProstatistix
Specialized analytics for prostate cancer research and biomarker discovery.
Coming soon
mAb-Target Affinity
Monoclonal antibody target affinity assessment with off-target risk analysis.
Off-target assessment in development
Our analytica portfolio
Trusted by global pharma leaders
Our workflows are used by leading pharmaceutical companies. We enabled Boehringer Ingelheim to build a single-cell RNA-seq atlas of over 1 million cells, processing over 2TB of data to uncover age-related macular degeneration (AMD) biomarkers.
Leadership

Yasin Kaymaz, PhD
Co-founder & Scientific Director
Ph.D. from UMass Medical School (2017), specializing in transcriptome analysis, mutation profiling, and NGS technologies. Former Bioinformatics Scientist at Harvard University developing analytical methods for single-cell RNA sequencing. Currently faculty member in Bioengineering at Ege University, leading the Bioinformatics and Molecular Genetics Laboratory.
yasinkaymaz@genfoquest.com
Talha Güler, PhD
Co-founder & Managing Director
Seasoned executive with 18 years of experience in medical device and IVD sectors. Proven track record in developing strategic initiatives and leading cross-functional teams. Career highlights include key roles at Johnson & Johnson, Becton Dickinson, and Managing Director at Technogen.
talhaguler@genfoquest.comScientific advisory board
Our bioinformatics technologies are supported by leading scientists in the community
Manuel Garber
UMass Medical School, USA
Jeffrey Bailey
Brown University, USA
Alper Kuclikural
UMass Medical School, USA
Ann Moormann
UMass Medical School, USA
Timothy Sackton
Harvard University, USA
Ozkan Aydemir
UMass Medical School, USA
Collaborative projects with Vivosel
Partnering with Vivosel for cutting-edge CAR-T cell development and off-target risk assessment for cancer therapies.
Lung Cancer CAR-T
Candidate selection and off-target risk assessment using in silico tests by GQA.
CD19 CAR-T Development
Computer-aided scFv design with Vivosel & Genfoquest Analytica collaboration.
Get in touch
Ready to unlock insights from your genomic data? Contact us for a free consultation and quote.